NCT01562626 Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors Status SUSPENDED Phase PHASE1/PHASE2
NCT01562067 Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy Status UNKNOWN Phase N/A
NCT01561911 A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment Status COMPLETED Phase PHASE1
NCT01553656 Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01548170 To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib Status COMPLETED Phase PHASE1
NCT01546519 A Study of Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degrees of Renal or Hepatic Function Status COMPLETED Phase PHASE1
NCT01542879 Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT01538563 Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01538537 Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01536691 Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone Status UNKNOWN Phase PHASE3
NCT01531478 Long-term Follow-up of Childhood Cancer Survivors in the Rhône-Alpes and Auvergne Regions of France Status COMPLETED Phase N/A
NCT01518621 Whole Brain Radiation With or Without Erlotinib for Brain Metastases From Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2